PROVECTUS BIOPHARMACEUTICALS, INC. Adjustments to Additional Paid in Capital, Warrant Issued
PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) reported Adjustments to Additional Paid in Capital, Warrant Issued of $488 for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-30.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2023-03-30
- PROVECTUS BIOPHARMACEUTICALS, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2021-06-30 was $488.00.
- PROVECTUS BIOPHARMACEUTICALS, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2020-09-30 was $865.00, a 5.46% decline year-over-year.
- PROVECTUS BIOPHARMACEUTICALS, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2019-09-30 was $915.00.
- PROVECTUS BIOPHARMACEUTICALS, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2019-06-30 was $10.11K.
- PROVECTUS BIOPHARMACEUTICALS, INC. adjustments to additional paid in capital, warrant issued for fiscal 2021 was $488.00, a 64.43% decline from fiscal 2020.
- PROVECTUS BIOPHARMACEUTICALS, INC. adjustments to additional paid in capital, warrant issued for fiscal 2020 was $1.37K, a 88.01% decline from fiscal 2019.
- PROVECTUS BIOPHARMACEUTICALS, INC. adjustments to additional paid in capital, warrant issued for fiscal 2019 was $11.44K.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 6 month | Adjustments to Additional Paid in Capital, Warrant Issued 8 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|---|---|
| 2021-12-31 | $488.00 10-K · filed 2023-03-30 | |||
| 2021-06-30 | $488.00 10-Q · filed 2022-11-09 | |||
| 2020-12-31 | $1.37K 10-K · filed 2022-03-29 | |||
| 2020-09-30 | $865.00 10-Q · filed 2021-11-10 | |||
| 2019-12-31 | $11.44K 10-K · filed 2020-03-05 | |||
| 2019-09-30 | $915.00 10-Q · filed 2020-11-12 | $11.03K derived: sum of 2 quarters · filed 2020-11-12 | ||
| 2019-06-30 | $10.11K 10-Q · filed 2020-11-12 | |||
| 2005-12-31 | $1.57M 10-Q · filed 2012-11-08 | |||
| 2002-12-31 | $126.59K 10-Q · filed 2014-08-07 |